Kühn S H, de Kock M A, Gevers W
Chest. 1978 Aug;74(2):150-6. doi: 10.1378/chest.74.2.150.
The measurement of the activity of acid hydrolases and of alkaline phosphatase in bronchial aspirates obtained through bronchoscopic procedures from a series of 300 patients forms the basis for a screening program to diagnose bronchial malignant neoplasms more effectively. We define such a screening test as one permitting rapid measurements indicative of pathologic abnormalities and producing a preliminary diagnosis which, if in error, yields preferably a false-positive result. Using this approach, we demonstrated that an elevation of the activity of alkaline phosphatase or cathepsin D predicts a 50 percent likelihood of cancer, but elevation of both the concentrations of alkaline phosphatase and cathepsin D has an additive prediction of 71 percent. Data obtained in this study showed that the presence of a pulmonary tumor can cause increased levels of alkaline phosphatase or cathepsin D (or both) in bronchial aspirates before the presently accepted methods yield a diagnostic result. Furthermore, those patients with an elevated activity of alkaline phosphatase or cathepsin D (or both) but with no histologically demonstrable pulmonary carcinoma can be reexamined intermittently.
通过支气管镜检查从300例患者获取支气管吸出物,测定其中酸性水解酶和碱性磷酸酶的活性,这为更有效地诊断支气管恶性肿瘤的筛查计划奠定了基础。我们将这样一种筛查试验定义为一种能够快速测量、指示病理异常并做出初步诊断的试验,若诊断有误,最好产生假阳性结果。采用这种方法,我们证明碱性磷酸酶或组织蛋白酶D活性升高预示患癌可能性为50%,但碱性磷酸酶和组织蛋白酶D浓度均升高时,联合预测率为71%。本研究获得的数据表明,在目前公认的方法得出诊断结果之前,肺部肿瘤的存在可导致支气管吸出物中碱性磷酸酶或组织蛋白酶D(或两者)水平升高。此外,碱性磷酸酶或组织蛋白酶D(或两者)活性升高但无组织学证实的肺癌的患者可进行定期复查。